10-QPeriod: Q2 FY2010

UNITEDHEALTH GROUP INC Quarterly Report for Q2 Ended Jun 30, 2010

Filed August 5, 2010For Securities:UNH

Summary

UnitedHealth Group Inc. (UNH) reported solid financial performance for the second quarter and first half of 2010, demonstrating continued growth and operational strength. Total revenues increased by 7% and 6% respectively for the three and six-month periods, primarily driven by organic growth in risk-based benefit offerings within the public and senior markets, as well as strong performance in its health services segments. The company also saw significant improvements in earnings from operations and net earnings, with diluted EPS growing 36% year-over-year for the quarter. This growth was supported by effective medical cost management, favorable prior period medical cost development, and strategic debt management, including a tender offer to refinance debt and improve interest rate exposure. The company also continued its commitment to shareholder returns through increased dividends and an active share repurchase program. Despite a challenging economic environment and the ongoing complexities of healthcare reform legislation, UnitedHealth Group maintained a strong balance sheet and robust cash flows from operations, which increased by 20% for the first half of the year. The company's diversified business model and disciplined approach to underwriting and pricing appear to be effectively navigating these headwinds. Management remains focused on operational efficiency and strategic growth opportunities across its health benefits and health services segments.

Financial Statements
Beta
Revenue$23.26B
Cost of Revenue$534.00M
Gross Profit$22.73B
SG&A Expenses$3.36B
Operating Expenses$21.36B
Operating Income$1.90B
Interest Expense$119.00M
Net Income$1.12B
EPS (Basic)$1.00
EPS (Diluted)$0.99
Shares Outstanding (Basic)1.13B
Shares Outstanding (Diluted)1.14B

Key Highlights

  • 1Total revenues increased by 7% to $23.26 billion for the quarter and 6% to $46.46 billion for the six months ended June 30, 2010, driven by growth in public and senior markets and health services.
  • 2Earnings from operations rose significantly, up 32% to $1.90 billion for the quarter and 26% to $3.92 billion for the six months, indicating improved profitability and operational efficiency.
  • 3Net earnings increased by 31% to $1.12 billion for the quarter and 26% to $2.31 billion for the six months, demonstrating strong bottom-line performance.
  • 4Diluted earnings per share (EPS) grew by 36% to $0.99 for the quarter and 31% to $2.02 for the six months, signaling enhanced shareholder value.
  • 5Medical costs were managed effectively, with a medical care ratio of 81.5% for the quarter and 81.4% for the six months, down from 83.6% and 83.0% respectively in the prior year, partly due to favorable prior period medical cost development.
  • 6The company completed a debt tender offer in February 2010, reducing outstanding debt and aiming to better match interest rate exposure.
  • 7Shareholder returns were prioritized, with an increase in the quarterly cash dividend and $1.2 billion in share repurchases during the first six months of 2010.

Frequently Asked Questions

Revenue growth was primarily driven by strong organic growth in risk-based benefit offerings in its public and senior markets businesses, alongside increases in customers served by its health services segments, particularly in pharmaceutical benefit management and health care technology. Growth in commercial premium rate increases also contributed.

Medical costs were managed effectively, leading to a decrease in the medical care ratio. This improvement was partly due to overall growth in the business and medical cost inflation being offset by favorable net development of prior period medical costs. For the six months ended June 30, 2010, there was $580 million in net favorable medical cost development related to prior fiscal years, attributed to more efficient claims handling and lower-than-expected health system utilization.

UnitedHealth Group demonstrated a commitment to shareholder returns. In May 2010, the company increased its quarterly cash dividend and moved to a quarterly payment cycle. Additionally, during the first six months of 2010, the company repurchased approximately 39 million shares of common stock for an aggregate cost of $1.2 billion, as part of its ongoing share repurchase program.

The company acknowledged the significant impact of the Health Reform Legislation (PPACA). While it anticipates new growth opportunities, it also noted potential risks such as increased medical costs, changes in underwriting policies, and uncertainties regarding future regulations. The company is actively adapting its business practices and pricing strategies to comply with the legislation's provisions as they roll out, with many aspects expected to take effect over the next few years.